, will1 ctll;~~lol, c~~~l~c d ( l c d ill pilrolfi!~ and scctio~lcd. Tlley were stailled wit11 Llle irrdirccl nlctllod using enzyme labelc(l alltiho(ly. 'l'llc ~)osilive stailll~~g was observed ill thc cytol)las~n of Ilcl)alocytes, I<ul~ffcr cells arid c~~~l o t l~c l i a l cells, suggestirrg tllat tllesc type cells contain xanthine (lelrydrogcnase. After isolation of hcpatocytes most of xantlline dcl~ytlrogcnnsr was recovered in 100,000xg supernata~ll fraction from Ilomogcrralc of lrepatocytes and Llle specific activity of enzyme was similar Lo tlrat ill 100,000xg superrratallt fraction fl-om I~omogcr~ale o l liver. P a l e l l a . University of Michigan, Department of I n t e r n a l Medicine, Ann Arbor, Michigan Human adenine phosphoribosyltransferase (APRT) deficiency i s a r e l a t i v e l y common genetic disorder caused by a defective APRT gene, r e s u l t i n g i n 2,8-dihydroxyadenine u r o l i t h i a s i s . The k i n e t i c p r o p e r t i e s of APRT from APRT-deficient Japanese s u b j e c t s showed s i m i l a r abnormalities suggesting a d i s t i n c t "Japanese-type* mutation.
Nucleotide sequence a n a l y s i s of APRT genomic DNA from WR2, a Japanese-type homozygote, i d e n t i f i e d a T t o C s u b s t i t u t i o n i n exon 5 on both a l l e l e s (~e t l~~+~h r ) .
RNase mapping a n a l y s i s revealed t h a t s i x other Japanese-type homozygotes c a r r i e d the same mutation on a t l e a s t one a l l e l e .
After amplifying the region of t h e APRT genomic DNA t h a t contains the Japanese-type mutation by the polymerase chain r e a c t i o n (PCR), dot-blot a n a l y s i s was performed using normal and mutated a l l e l e s p e c i f i c oligonucleotide (ASO) probes.
This method demonstrated t h a t a l l seven Japanese-type homozygotes c a r r i e d the same mutation on both a l l e l e s .
The dot-blots c l e a r l y d i s t i n g u i s h normal. Japanese-type heterozygotes and Japanese-type homozygotes. PCR of genomic sequences and AS0 hybridization i s a u s e f u l t o o l f o r d e t e c t i o n of common mutations i n defined populations. such a s "Japanese-type" APRT deficiency. P388 m u r i n e l e~k e m i f~c e l l s w e r e i n c u b e t e d w i i h tyg d i f f e r e n t t y p e s o f C -l a b e l e d B H A C , ( c y t o s i n e -2 -C) BHAC a n d ( a c y l -1 -. *C)BHAC, a n d DNA w a s e x t r a c t e d w i t h p h e n o l . And t h e n t h e p h e n o l e x t r a c t e d DNA was h y d r o l y z e d b y n u c l e a s e P 1 a n d a n a l y z e d w i t h h i g hp e r f o r m a n c e l i q u
INCORPORATION OF N~-B E H E I J O L Y -~-@ -D -

l d c h r o m a t o g r a p h y ( H P L C ) . T h e r a d i o a ct i v i i y o f DNA, f r o m t h e c e l l s i n c u b a t e d w i i h ( c y t o s i n e -2-C)BHAC,was d e t e c t e d a s Ara-CMP. B u t t h e r a d l o a c -I i v i t y o f DNA, f r o m t h e c e l l s i n c u b a t e d w i t h ( a c y l -1 -C)BHAC,was a l m o s t n o t d e t e c t e d . On t h e o t h e r h a n d , t h e m a i n r a d i o a c t i v i t y o f a c i d s o l u b l e f r a c t i o n w a s d e t e r m i n e d a s Ara-CTP. On t h e b a s i s o f o u r r e s u l p , BrlAC i s n o t p h o s p h o r y l a t e d d i r e c t l y t o p r o d u c e N -
b e h e n o l y -a r a --C T P , b u t m a i n l y o n c e c o n v e r t e d t o Ara-C a n d i t s u b s e q u e n t l y p r o d u c e s A r a -C T P , t h e a c t i v e m e t a b o l i t e o f t h e d r u g , a n d r h e n i n c o r p o r a t e d i n t o DNA. The aim of t h i s study was t o examine whether pyrazinamide and a l l o p u r i n o l were metabolized i n t h r e e xanthinuric p a t i e n t s of two f a m i l i e s of hereditary xanthinuria lacking xanthine oxidase because we were i n t e r e s t e d i n whether both pyrazinamide and a l l o p u r i n o l were oxidized only by xanthine oxidase o r by other kinds of oxidase. A xanthinuric p a t i e n t , t h e propositus of a family of xanthinuria could n e i t h e r metabolize pyrazinamide i n t o 5-hydroxypyrazinamide nor a l l o p u r i n o l i n t o oxypurinol. Two xanthinuric p a t i e n t s , the propositus of the o t h e r family of xanthinuria and h i s e l d e r brother could metabolize both pyrazinamide i n t o 5-hydroxypyrazinamide and a l l o p u r i n o l i n t o oxypurinol. These r e s u l t s suggests t h a t xanthinuria c o n s i s t s of a t l e a s t two subgroups; one does not possess pyrazinamidea l l o p u r i n o l oxidizing enzyme(s) other than xanthine oxidase o r possesses a v a r i a n t form of xanthine oxidase which can n e i t h e r metabolize oxypurines nor pyrazinamide o r a l l o p u r i n o l , and t h e other possesses p y r a z i n a m i d e -a l l o p u r i n o l oxidizing enzyme(s) or possesses the o t h e r v a r i a n t form of xanthine oxidase which can not metabolize oxypurines but can do both pyrazinamide and a l l o p u r i n o l . an "enhryrmic" transcript (3.4 W ) and peptide: postnatal s k e l e t a l mujcle c o n t a i n s an "adult" transcript (2.5 Kb) and peptide. ' Ihe l a t t e r are restricted to striated -1e. E x d u c t i o n o f the a d u l t p e p t i d e is c o n t r o l l e d by t r a n s c r i p t switching, increase i n transcript a k u d x c e d u r i n g rmscle developnent and p o s s i b l y efficiency of t r a n s l a t i o n . 3) Four p a t i e n t s w i t h inherited deficiency of AMP-D have been evaluated w i t h these probes. AlthMlgh b m m o r e a d i v e p e p t i d e is absent f m their s k e l e t a l -le, the abunjanoe o f t h e 2.5 W nwcles p e c i f i c transcript is normal. We conclude f m these s t u d i e s that 1). AMP-D expression is c o n t r o l l e d a t r m l t i p l e steps during m y c q t e d e v e l o p w r t 2) I n h e r i t e d d e f i c i e n c y o f the m l es p e c i f i c isofonn cannot be explained by a d e f e c t i n t r a n s c r i p t switching o r rate o f t r a n s c r i p t i o n ! suggesting a d e f e c t i n t r a n s l a t i o n o r a sirqle base substitution.
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